Literature DB >> 21127287

Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007.

Julian A Abrams1, Reem Z Sharaiha, Lou Gonsalves, Charles J Lightdale, Alfred I Neugut.   

Abstract

BACKGROUND: The timing of onset of the rise in incidence of esophageal adenocarcinoma (EAC) has not been clearly defined, and doing so may provide clues with regard to exposures associated with the changed epidemiology of this malignancy. We therefore aimed to investigate historical trends in the incidence of EAC and other upper gastrointestinal malignancies.
METHODS: We did a population-based study using Connecticut Tumor Registry (1940-2007) and Surveillance, Epidemiology, and End Results (SEER; 1973-2007) data. Age-adjusted incidence rates (per 100,000 person-years) were calculated for EAC and other upper gastrointestinal malignancies.
RESULTS: The incidence of EAC remained relatively constant until 1965-69, and then rose from 0.41 (95%CI, 0.26-0.56) to 1.31 (95%CI 1.07-1.54) in 1978-82 and 5.31 (95%CI 4.89-5.73) in 2003-07. The incidence of gastric cardia cancer began to rise in the 1950s and plateaued in the 1990s. The incidence of esophageal squamous cell carcinoma began to decrease around 1980. The trends from Connecticut Tumor Registry data closely mirrored those from SEER data.
CONCLUSIONS: The incidence of EAC began to rise in the late 1960s, predating the rise in obesity by a decade. Reduced infection rates of Helicobacter pylori, changes in microbiome, or other exposures may have contributed to the changed epidemiology of this malignancy. IMPACT: Analysis of historical data of trends in EAC incidence implicate a change in environmental factors from the mid-20th century as primarily responsible for the initial rise in EAC incidence, predating the rise in obesity prevalence in the United States by over a decade. ©2011 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 21127287      PMCID: PMC3018857          DOI: 10.1158/1055-9965.EPI-10-0802

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  20 in total

1.  Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.

Authors:  Prateek Sharma; Gary W Falk; Allan P Weston; Dean Reker; Mark Johnston; Richard E Sampliner
Journal:  Clin Gastroenterol Hepatol       Date:  2006-04-17       Impact factor: 11.382

2.  Bacterial biota in reflux esophagitis and Barrett's esophagus.

Authors:  Zhiheng Pei; Liying Yang; Richard M Peek; Steven M Jr Levine; David T Pride; Martin J Blaser
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Overweight and obesity in the United States: prevalence and trends, 1960-1994.

Authors:  K M Flegal; M D Carroll; R J Kuczmarski; C L Johnson
Journal:  Int J Obes Relat Metab Disord       Date:  1998-01

4.  Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer.

Authors:  L Rehnberg-Laiho; H Rautelin; P Koskela; S Sarna; E Pukkala; A Aromaa; P Knekt; T U Kosunen
Journal:  Epidemiol Infect       Date:  2001-02       Impact factor: 2.451

5.  Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium.

Authors:  Michael B Cook; Farin Kamangar; David C Whiteman; Neal D Freedman; Marilie D Gammon; Leslie Bernstein; Linda M Brown; Harvey A Risch; Weimin Ye; Linda Sharp; Nirmala Pandeya; Penelope M Webb; Anna H Wu; Mary H Ward; Carol Giffen; Alan G Casson; Christian C Abnet; Liam J Murray; Douglas A Corley; Olof Nyrén; Thomas L Vaughan; Wong-Ho Chow
Journal:  J Natl Cancer Inst       Date:  2010-08-17       Impact factor: 13.506

6.  Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89.

Authors:  T Zheng; S T Mayne; T R Holford; P Boyle; W Liu; Y Chen; M Mador; J Flannery
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

7.  Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas.

Authors:  Douglas A Corley; Ai Kubo
Journal:  J Natl Cancer Inst       Date:  2004-09-15       Impact factor: 13.506

8.  The cohort effect and Helicobacter pylori.

Authors:  N Banatvala; K Mayo; F Megraud; R Jennings; J J Deeks; R A Feldman
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

9.  Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden.

Authors:  L E Hansson; P Sparén; O Nyrén
Journal:  Int J Cancer       Date:  1993-05-28       Impact factor: 7.396

10.  Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites.

Authors:  J Powell; C C McConkey
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

View more
  40 in total

1.  The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.

Authors:  Chung Yin Kong; Kevin J Nattinger; Tristan J Hayeck; Zehra B Omer; Y Claire Wang; Stuart J Spechler; Pamela M McMahon; G Scott Gazelle; Chin Hur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-19       Impact factor: 4.254

2.  The emerging medical ecology of the human gut microbiome.

Authors:  John W Pepper; Simon Rosenfeld
Journal:  Trends Ecol Evol       Date:  2012-04-25       Impact factor: 17.712

3.  New observations regarding Helicobacter pylori and gastric cancer in Mongolia.

Authors:  Boldbaatar Gantuya; Dashdorj Bolor; Khasag Oyuntsetseg; Yansan Erdene-Ochir; Ruvjir Sanduijav; Duger Davaadorj; Tegshee Tserentogtokh; Dashdorj Azzaya; Tomohisa Uchida; Takeshi Matsuhisa; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2018-06-08       Impact factor: 5.753

4.  Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.

Authors:  Jennifer Drahos; Qian Xiao; Harvey A Risch; Neal D Freedman; Christian C Abnet; Lesley A Anderson; Leslie Bernstein; Linda Brown; Wong-Ho Chow; Marilie D Gammon; Farin Kamangar; Linda M Liao; Liam J Murray; Mary H Ward; Weimin Ye; Anna H Wu; Thomas L Vaughan; David C Whiteman; Michael B Cook
Journal:  Int J Cancer       Date:  2015-08-26       Impact factor: 7.396

5.  Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma.

Authors:  Erik J Snider; Griselda Compres; Daniel E Freedberg; Hossein Khiabanian; Yael R Nobel; Stephania Stump; Anne-Catrin Uhlemann; Charles J Lightdale; Julian A Abrams
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-29       Impact factor: 4.254

6.  Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan.

Authors:  Shigeto Koizumi; Satoru Motoyama; Katsunori Iijima
Journal:  J Gastroenterol       Date:  2017-11-14       Impact factor: 7.527

7.  Positive correlation between endoscopist radiofrequency ablation volume and response rates in Barrett's esophagus.

Authors:  David I Fudman; Charles J Lightdale; John M Poneros; Gregory G Ginsberg; Gary W Falk; Maureen Demarshall; Milli Gupta; Prasad G Iyer; Lori Lutzke; Kenneth K Wang; Julian A Abrams
Journal:  Gastrointest Endosc       Date:  2014-02-22       Impact factor: 9.427

8.  Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.

Authors:  Reem Z Sharaiha; Daniel E Freedberg; Julian A Abrams; Y Claire Wang
Journal:  Dig Dis Sci       Date:  2014-05-03       Impact factor: 3.199

9.  Does the Incidence of Adenocarcinoma of the Esophagus and Gastric Cardia Continue to Rise in the Twenty-First Century?-a SEER Database Analysis.

Authors:  A Dubecz; N Solymosi; R J Stadlhuber; M Schweigert; H J Stein; J H Peters
Journal:  J Gastrointest Surg       Date:  2013-11-15       Impact factor: 3.452

10.  Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study.

Authors:  Prasad G Iyer; Bijan J Borah; Herbert C Heien; Ananya Das; Gregory S Cooper; Amitabh Chak
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-13       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.